ConductScience.org, home

Paper1004574

Induction of oncogenic transformation in vitro by ultraviolet light.

Chan GL and 1 other. Nature, 1976. Cited by 64 papers, by iCite.

Cite this record

ConductScience Library. Induction of oncogenic transformation in vitro by ultraviolet light. Papers, record 1004574. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/1004574

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Induction of oncogenic transformation in vitro by ultraviolet light.
PubMed
Journal
Nature
PubMed
Year
1976
PubMed
Publication types
Journal Article, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
64
iCite
Relative citation ratio, by iCite
2.22
iCite
Revised in PubMed
2019-06-17
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Chan GLG L
2Little JBJ B

Source PubMed

Download CSV of authors

Topics7

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Cell Transformation, NeoplasticMajor topic
Ultraviolet RaysMajor topic
Cell Division
Cell Line
Cell Survival
DNA Repair
Dose-Response Relationship, Radiation

Source PubMed

Download CSV of topics

Cited by7

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 64 citations.

PMIDTitleJournalYearIn PapersSource
10501656Re-expression of SPR1 in breast cancer cells by phorbol 12-myristate 13-acetate (PMA) or UV irradiation is mediated by the AP-1 binding site in the SPR1 promoter.Mol Med1999https://conductscience.org/library/papers/10501656PubMed
6303378In vitro genotoxic activities of fibrous erionite.Br J Cancer1983https://conductscience.org/library/papers/6303378PubMed
3857629An initiator of carcinogenesis selectively and stably inhibits stem cell differentiation: a concept that initiation of carcinogenesis involves multiple phases.Proc Natl Acad Sci U S A1985https://conductscience.org/library/papers/3857629PubMed
3015180The in vitro genetic effects of fibrous erionite and crocidolite asbestos.Br J Cancer1986https://conductscience.org/library/papers/3015180PubMed
486316Correlation of in vitro transformation with in vivo tumorigenicity in 10T1/2 mouse cells exposed to UV light.Br J Cancer1979https://conductscience.org/library/papers/486316PubMed
230490Passage of phenotypes of chemically transformed cells via transfection of DNA and chromatin.Proc Natl Acad Sci U S A1979https://conductscience.org/library/papers/230490PubMed
150601Induction of ouabain-resistant mutations in C3H 10T1/2 mouse cells by ultraviolet light.Proc Natl Acad Sci U S A1978https://conductscience.org/library/papers/150601PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/1004574

GET https://conductscience.org/api/papers/v1/1004574/authors